Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)

Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)

<h4>Aims</h4> <p>Hypoglycaemia is a significant risk in insulin treated type 2 diabetes and has been associated with future risk of cardiovascular events. We compared the frequency of low-glucose events using continuous glucose monitoring (CGM) with that of self-reported hypoglyce...

Full description

Bibliographic Details
Main Authors:	Levy, J, Davies, M, Holman, R
Format:	Journal article
Published:	Elsevier 2017

Similar Items

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

Hypoglycaemia in clinical diabetes /
by: Frier, Brian M, et al.
Published: (2007)

Blood glucose self-monitoring in type 2 diabetes: A randomised controlled trial
by: Farmer, A, et al.
Published: (2009)

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
by: Farmer, A, et al.
Published: (2009)

Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study.
by: Jenkins, N, et al.
Published: (2011)

Initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) trial: an interview study of patients' and health professionals' experiences.
by: Jenkins, N, et al.
Published: (2010)

Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial
by: French, D, et al.
Published: (2008)

Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial.
by: French, D, et al.
Published: (2008)

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
by: Holman, R, et al.
Published: (2014)

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.
by: Farmer, A, et al.
Published: (2007)

Evaluation of a continuous glucose monitoring system in diabetic dogs.
by: Davison, L, et al.
Published: (2003)

Experience of hypoglycaemia is associated with changes in beliefs about diabetes in patients with type 2 diabetes.
by: Malanda, U, et al.
Published: (2011)

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
by: Holman, R, et al.
Published: (2014)

IMPAIRED BETA-CELL FUNCTION BUT NOT SELECTIVE GLUCOSE INSENSITIVITY IN DIET-TREATED TYPE-2 DIABETIC SUBJECTS
by: Camps, I, et al.
Published: (1993)

Cost-effectiveness of real time continuous glucose monitoring to target glucose control in preterm infants
by: Petrou, S, et al.
Published: (2021)

Evaluation of a continuous glucose monitoring system in cats with diabetes mellitus.
by: Ristic, J, et al.
Published: (2005)

Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
by: Farmer, A, et al.
Published: (2012)

Cost-effectiveness of self-monitoring of blood glucose for the management of patients with non-insulin treated type 2 diabetes: economic evaluation of the DiGEM trial
by: Simon, J, et al.
Published: (2007)

Appropriateness of action prompts for hypoglycaemia and hyperglycaemia in type 2 diabetes self-management apps
by: Lum, Elaine, et al.
Published: (2022)

Self-monitoring of blood glucose did not improve glycaemic control in patients with type 2 diabetes not treated with insulin: Commentary
by: Farmer, A, et al.
Published: (2008)

Evaluation of continuous glucose monitoring systems
by: Li, Guang, M. Eng. Massachusetts Institute of Technology
Published: (2009)

Optimizing blood glucose control in type 2 diabetes: an approach based on fasting blood glucose measurements.
by: Holman, R, et al.
Published: (1988)

Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.
by: Hill, N, et al.
Published: (2011)

Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups
by: Hill, N, et al.
Published: (2011)

Sulphonylureas and hypoglycaemia.
by: Ferner, R, et al.
Published: (1988)

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.
by: Simon, J, et al.
Published: (2008)

Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic review.
by: Farmer, A, et al.
Published: (2009)

Blood glucose and prognosis in children with presumed severe malaria: is there a threshold for 'hypoglycaemia'?
by: Willcox, M, et al.
Published: (2010)

Glucagon and glucose counterregulation: pancreatic α-cell function and dysfunction during hypoglycaemia
by: Hamilton, A
Published: (2018)

CONTROL OF MATURITY-ONSET DIABETES BY HOME OR CLINIC MONITORING OF FASTING PLASMA GLUCOSE
by: Howedavies, S, et al.
Published: (1978)

Severe hypoglycaemia in unselected patients with type 1 diabetes: A cross-sectional multicentre survey
by: Pramming, S, et al.
Published: (2000)

Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection.
by: Pedersen-Bjergaard, U, et al.
Published: (2004)

Insulinoma - Presenting with reactive hypoglycaemia rather than fasting hypoglycaemia
by: Kar, P, et al.
Published: (2006)

The effect of blood glucose selfmonitoring in patients with non-insulin treated type 2 diabetes
by: Wade, AN
Published: (2005)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
by: Holman, R, et al.
Published: (2009)

Practice of self-monitoring blood glucose among insulin-treated diabetic patients in Hospital Serdang
by: Zahari Sham, Siti Yazmin, et al.
Published: (2016)

Improving glucose control and cardiovascular risk in general practice Type 2 diabetes.
by: Potts, N, et al.
Published: (2003)

Continuous glucose monitoring and U.S. market strategy
by: Sharma, Shweta Humad
Published: (2014)

Impact of self-monitoring of blood glucose on the management of patients with non-insulin treated diabetes: an open-label parallel group randomised trial
by: Farmer, A, et al.
Published: (2007)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
by: Hermans, M, et al.
Published: (1996)